Loading...

India-based health platform Lybrate raises USD3 mn

Image

12-Apr-17 Indian health tech startup Lybrate has raised USD3 mn in new funding to achieve its goal of connecting patients with doctors in India and helping to raise awareness of basic medical practices. The startup’s biggest rival is Practo, which offers doctor-finding and health information, and has also raised several million US dollars in past month.

Read More

Gleneagles Global Hospitals launches a new facility in Bengaluru

Image

09-Apr-17 Gleneagles Global Hospitals, a Parkway Pantai Enterprise, has opened its newest facility in India, Richmond Road, spread over 15,000 sq ft, housing 10 core specialties with state-of-the-art equipment and diagnostics, offering multi-disciplinary care. Dr K Ravindranath, Chairman & Founder, said, “Our new hospital at Richmond Road is a significant addition to our ongoing efforts in medical excellence.” [image: ET Healthworld]

Read More

Indian healthcare startup Practo lays off 150 people

Image

08-Apr-17 Indian online doctor discovery and healthcare tech platform Practo has laid off 150 employees following its annual appraisal. The company said “this is a combination of performance and natural redundancies that emerge as we evolve our businesses and integrate our five acquisitions. We continue to rapidly grow our consumer and enterprise businesses and will continue to hire talent across the board”. [image: Times of India]

Read More

Healthcare devices in India registered 150% growth on Amazon

Image

07-Apr-17 According to data from Amazon.in, the healthcare category has grown 150% year on year with some of the top selling products in the category are blood glucose monitors, fitness trackers, and blood pressure monitors. The younger generation are driving these purchases that include for self-use and gifts for parents and grandparents. [image: ET Retail / Amazon]

Read More

Many American healthtech companies would have more success in emerging markets

Image

06-Apr-17 Global healthcare spending is roughly USD7 tn, according to the US Department of Commerce and many companies would have more success pursuing product approval in emerging markets as the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggested Matthew Hein, representative for the US DoC at the MedTech Intelligence Global Regulatory conference. [image: MedTech Intelligence]

Read More